MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Neuromyelitis optica {40000338}

Record Keys


Definition:
Neuromyelitis optica
Class:[  ]

Details


Other Terms:
NMO
Initialisation date:[  ]

Meta Information


ICD:[  ]
Category:[  ]
MedDra ID:
10077875
MedDra Level:
pt

Notes


[  ]

Shared Notes


[  ]


[Coverage other Diseases (Overlap > 0.25)]

DiseaseOverlapCommon increased OrganismCommon decreased Organism
Neuromyelitis optica 1.0000 15 (100%) : Acholeplasma | anaerobacter | Anaeroglobus | Bacteroides | Clostridium perfringens | Coprococcus | Corynebacterium | Flavobacterium | Flavonifractor | Oribacterium | Prevotella melaninogenica | Ruminococcus productus | Shigella | Streptococcus | Treponema socranskii 13 (100%) : Blautia | Candidatus phytoplasma | Coprococcus | Faecalibacterium | Fusicatenibacter | Lachnospiraceae | Lachnospiraceae incertae sedis | Peptostreptococcaceae | Prevotella copri | Prevotellaceae | Romboutsia | Roseburia | Sutterella
Autism 0.4410 4 (27%) : Bacteroides | Corynebacterium | Shigella | Streptococcus 8 (62%) : Blautia | Coprococcus | Fusicatenibacter | Lachnospiraceae | Peptostreptococcaceae | Prevotellaceae | Romboutsia | Roseburia
Parkinson's Disease 0.4026 4 (27%) : Bacteroides | Coprococcus | Shigella | Streptococcus 7 (54%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Prevotella copri | Prevotellaceae | Roseburia
HIV infection 0.4026 4 (27%) : Corynebacterium | Prevotella melaninogenica | Shigella | Streptococcus 7 (54%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Peptostreptococcaceae | Romboutsia | Roseburia
Irritable bowel syndrome 0.3692 3 (20%) : Bacteroides | Ruminococcus productus | Streptococcus 7 (54%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Lachnospiraceae incertae sedis | Prevotellaceae | Roseburia
Non-alcoholic fatty liver disease 0.3641 4 (27%) : anaerobacter | Bacteroides | Coprococcus | Streptococcus 6 (46%) : Blautia | Coprococcus | Faecalibacterium | Peptostreptococcaceae | Prevotella copri | Roseburia
Multiple Sclerosis 0.3590 5 (33%) : Bacteroides | Clostridium perfringens | Coprococcus | Shigella | Streptococcus 5 (38%) : Blautia | Faecalibacterium | Lachnospiraceae | Prevotella copri | Roseburia
Crohn's disease 0.3590 5 (33%) : Coprococcus | Flavobacterium | Prevotella melaninogenica | Shigella | Streptococcus 5 (38%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Roseburia
Obesity 0.3590 5 (33%) : Bacteroides | Coprococcus | Corynebacterium | Prevotella melaninogenica | Treponema socranskii 5 (38%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Roseburia
Chronic kidney disease 0.3590 5 (33%) : Bacteroides | Corynebacterium | Flavonifractor | Shigella | Streptococcus 5 (38%) : Coprococcus | Faecalibacterium | Prevotellaceae | Romboutsia | Roseburia
Colorectal cancer 0.3359 2 (13%) : Bacteroides | Streptococcus 7 (54%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Prevotella copri | Roseburia | Sutterella
Coronary artery disease 0.3308 3 (20%) : Bacteroides | Shigella | Streptococcus 6 (46%) : Blautia | Coprococcus | Faecalibacterium | Fusicatenibacter | Lachnospiraceae | Roseburia
Type 2 diabetes 0.3256 4 (27%) : Bacteroides | Corynebacterium | Shigella | Streptococcus 5 (38%) : Coprococcus | Faecalibacterium | Lachnospiraceae | Prevotella copri | Sutterella
Psoriasis 0.3256 4 (27%) : Bacteroides | Coprococcus | Flavobacterium | Streptococcus 5 (38%) : Coprococcus | Faecalibacterium | Lachnospiraceae | Prevotella copri | Sutterella
Cystic fibrosis 0.3256 4 (27%) : Bacteroides | Clostridium perfringens | Shigella | Streptococcus 5 (38%) : Blautia | Faecalibacterium | Lachnospiraceae | Prevotellaceae | Roseburia
Covid-19 0.3026 1 (7%) : Streptococcus 7 (54%) : Blautia | Coprococcus | Faecalibacterium | Fusicatenibacter | Lachnospiraceae | Romboutsia | Roseburia
Short Bowel Syndrome 0.2974 2 (13%) : Shigella | Streptococcus 6 (46%) : Blautia | Faecalibacterium | Fusicatenibacter | Lachnospiraceae | Peptostreptococcaceae | Roseburia
Schizophrenia 0.2923 3 (20%) : Clostridium perfringens | Flavonifractor | Shigella 5 (38%) : Coprococcus | Faecalibacterium | Fusicatenibacter | Lachnospiraceae | Sutterella
Primary sclerosing cholangitis 0.2923 3 (20%) : Bacteroides | Oribacterium | Streptococcus 5 (38%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Prevotella copri
Gastric carcinoma 0.2821 5 (33%) : Bacteroides | Corynebacterium | Prevotella melaninogenica | Shigella | Streptococcus 3 (23%) : Faecalibacterium | Prevotella copri | Roseburia
Major depressive disorder 0.2590 2 (13%) : Bacteroides | Streptococcus 5 (38%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae | Sutterella
Type 1 diabetes 0.2538 3 (20%) : Bacteroides | Clostridium perfringens | Streptococcus 4 (31%) : Faecalibacterium | Lachnospiraceae | Peptostreptococcaceae | Roseburia
Ulcerative Colitis 0.2538 3 (20%) : Bacteroides | Shigella | Streptococcus 4 (31%) : Blautia | Coprococcus | Lachnospiraceae | Roseburia
Alcoholism 0.2538 3 (20%) : Bacteroides | Corynebacterium | Streptococcus 4 (31%) : Blautia | Coprococcus | Faecalibacterium | Lachnospiraceae

[Coverage Factors (Overlap > 0.10)]

FactorOverlapCommon increased OrganismCommon decreased Organism
Protein powder consumption 0.1538 0 (0%) 4 (31%) : Blautia | Coprococcus | Lachnospiraceae | Roseburia